Vanta Bioscience Limited (BOM:540729)
India · Delayed Price · Currency is INR 22.83
0.00 (0.00%)
At close: Aug 5, 2026
Vanta Bioscience Revenue
In the fiscal year ending March 31, 2026, Vanta Bioscience had annual revenue of 18.16M INR, down -7.49%. Vanta Bioscience had revenue of 15.15M in the half year ending March 31, 2026, a decrease of -56.94%.
Revenue
18.16M
Revenue Growth
-7.49%
P/S Ratio
7.93
Revenue / Employee
n/a
Employees
36
Market Cap
144.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.16M | -1.47M | -7.49% |
| Mar 31, 2025 | 19.64M | -77.59M | -79.80% |
| Mar 31, 2024 | 97.23M | 34.47M | 54.92% |
| Mar 31, 2023 | 62.76M | -37.42M | -37.36% |
| Mar 31, 2022 | 100.18M | -331.32K | -0.33% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Palm Jewels | 1.85B |
| Tai Industries | 1.58B |
| Kizi Apparels | 426.36M |
| MT Educare | 361.40M |
| Technopack Polymers | 83.74M |
| Clio Infotech | 30.06M |
| Trans Freight Containers | 18.79M |
| Rekvina Laboratories | 12.65M |